Related Experiment Video
Updated: Oct 6, 2025

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
The Detection of Hyaline Casts in Patients Without Renal Dysfunction Suggests Increased Plasma BNP
Elisa Shikata1,2, Ryosuke Hattori3, Mitsuo Hara3
1Department of Laboratory Medicine, Nihon University Hospital, Tokyo, Japan.
Insights
Hyaline casts in urine may appear in patients with normal kidney function. Elevated hyaline casts (2+) may indicate a need to check brain natriuretic peptide (BNP) levels.
Area of Science:
- Nephrology
- Cardiology
- Clinical Chemistry
Background:
- Urinary casts aid in kidney disease diagnosis.
- Hyaline casts were not previously considered pathognomonic.
- Hyaline casts can be found in patients with normal renal function, particularly those undergoing cardiovascular treatment.
Purpose of the Study:
- To evaluate the clinical background of patients with hyaline casts and normal renal function.
- To investigate the correlation between hyaline casts and plasma brain natriuretic peptide (BNP) levels.
Main Methods:
- Analysis of 3137 patient samples from a cardiovascular division (2014-2018).
- Inclusion criteria: eGFR > 60 mL/min/1.73 m² and absent or trace proteinuria.
- Comparison of plasma BNP levels in patients with varying degrees of hyaline casts and age-matched controls using Kruskal-Wallis analysis.
Main Results:
- 147 samples (4.7%) showed hyaline casts.
- Median BNP levels were significantly higher in patients with 2+ and ≥3+ hyaline casts compared to controls (P<0.05 and P<0.01, respectively).
- Median BNP levels increased with the degree of hyaline casts observed.
Conclusions:
- Hyaline casts can be present in individuals with normal renal function.
- A finding of 2 or more pluses of hyaline casts warrants consideration for plasma BNP level assessment.
- This suggests a potential link between hyaline casts and cardiac status in non-renal dysfunction patients.
Background And Aim:
Casts in urinary sediments are useful in the identification of kidney diseases. Among them, hyaline casts have not previously been considered as pathognomonic. However, hyaline casts can occasionally be found in patients undergoing cardiovascular treatment without renal dysfunction. We evaluated the background of these patients and also investigated their levels of plasma brain natriuretic peptide (BNP).
Materials And Methods:
Samples from patients who visited the Division of Cardiovascular Disease at Nihon University Hospital (2014-2018) were examined. We set extract conditions from the laboratory information system database, setting the threshold over 60 mL/min/1.73 m2 for the estimated glomerular filtration rate (eGFR), and proteinuria as absent (-) or trace (±). One hundred forty-seven of 3137 (4.7%) samples showed hyaline casts (M:F=102:45, mean age 69.5±11.2 years). Samples with hyaline casts were divided into three rank groups. We compared BNP levels among each cast group and age-matched controls using Kruskal-Wallis analysis.
Results:
The median BNP levels of the controls and the three casts groups were 23.3 pg/mL in the controls, 31.1 pg/mL in group (1+), 35.5 pg/mL in group (2+), and 45.8 pg/mL in group (≥3+). The median BNP levels differed significantly between two casts groups (group (2+) and group (≥3+)) and the control group (P<0.05 and P<0.01, respectively).
Conclusion:
Hyaline casts could be detected in patients with normal renal function. When hyaline casts are more than 2+, the physician should consider checking plasma BNP levels of the patient.
More Related Videos
Related Concept Videos
Serum Studies: Renal Function Tests
Urine Studies I: Urinalysis
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Nephrotic Syndrome II : Assessment and Medical Management
Hypertension III: Clinical Manifestations and Diagnostic Studies
Nephrotic Syndrome I : Introduction

